| Evaluate the Efficacy and Safety of CTO0307 in Adults With Presbyopia (NCT07723716) | Taejoon Pharmaceutical Co., Ltd. | 2025-02-26 |
| Comparing Efficacy and Safety of CTO0303 in Pediatric Subjects (NCT06609525) | Taejoon Pharmaceutical Co., Ltd. | 2024-05-09 |
| A Phase 3 Clinical Trials for Bowel Preparation for Colonoscopy (NCT06287606) | Taejoon Pharmaceutical Co., Ltd. | 2023-08-29 |
| Comparing Efficacy and Safety of TJO-083 in Dry Eye Diseases Patients (NCT06427031) | Taejoon Pharmaceutical Co., Ltd. | 2023-07-14 |
| A Phase 3 Trial in Bowel Preparation for Colonoscopy (NCT05870553) | Taejoon Pharmaceutical Co., Ltd. | 2023-01-30 |
| A Prospective, Randomized, Investigator-blinded, Parallel, Multi-center, Phase 3 Trial (NCT05670470) | Taejoon Pharmaceutical Co., Ltd. | 2022-09-21 |
| A Phase 1 Clinical Trial to Explore Systemic Exposure of CTO0101 Eye Drops, Safety and Local Tolerability in Healthy Adults (NCT05262179) | Taejoon Pharmaceutical Co., Ltd. | 2021-10-05 |
| Evaluating the Efficacy and Safety of TJO-087 in Moderate to Severe Dry Eye Disease Patients (NCT05245604) | Taejoon Pharmaceutical Co., Ltd. | 2020-06-19 |
| Evaluating HA 0.15% Compared With Cyclosporine 0.05%, and Efficacy of Combination Therapy in Dry Eye Disease Patients (NCT04127851) | Taejoon Pharmaceutical Co., Ltd. | 2019-11-12 |
| Evaluating the Efficacy and Safety of Xalost S in Glaucoma Patients. (NCT04164459) | Taejoon Pharmaceutical Co., Ltd. | 2018-12-19 |
| A Prospective, Randomized, Single-blinded (Evaluator), Parallel, Multi-center, Phase 3 Trial in Bowel Preparation for Colonoscopy (NCT03544944) | Taejoon Pharmaceutical Co., Ltd. | 2018-01-02 |